James F. Oliviero

2014

In 2014, James F. Oliviero earned a total compensation of $1.8M as Former Chief Financial Officer at Keryx Biopharmaceuticals, a 22% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$146,000
Option Awards$546,167
Salary$348,333
Stock Awards$732,219
Total$1,772,719

Oliviero received $732.2K in stock awards, accounting for 41% of the total pay in 2014.

Oliviero also received $146K in non-equity incentive plan, $546.2K in option awards and $348.3K in salary.

Rankings

In 2014, James F. Oliviero's compensation ranked 5,020th out of 13,032 executives tracked by ExecPay. In other words, Oliviero earned more than 61.5% of executives.

ClassificationRankingPercentile
All
5,020
out of 13,032
62nd
Division
Manufacturing
1,790
out of 4,966
64th
Major group
Chemicals And Allied Products
592
out of 1,686
65th
Industry group
Drugs
452
out of 1,365
67th
Industry
Pharmaceutical Preparations
361
out of 1,043
65th
Source: SEC filing on April 15, 2016.

Oliviero's colleagues

We found two more compensation records of executives who worked with James F. Oliviero at Keryx Biopharmaceuticals in 2014.

2014

Ron Bentsur

Keryx Biopharmaceuticals

Chief Executive Officer

2014

Gregory Madison

Keryx Biopharmaceuticals

Chief Executive Officer

You may also like